{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,20]],"date-time":"2025-06-20T10:47:49Z","timestamp":1750416469447},"reference-count":24,"publisher":"The Fukushima Society of Medical Science","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Fukushima J. Med. Sci.","FJMS"],"published-print":{"date-parts":[[2012]]},"DOI":"10.5387\/fms.58.127","type":"journal-article","created":{"date-parts":[[2012,12,13]],"date-time":"2012-12-13T22:43:16Z","timestamp":1355438596000},"page":"127-135","source":"Crossref","is-referenced-by-count":5,"title":["ASSOCIATION OF THE TOLL-LIKE RECEPTOR 9 GENE POLYMORPHISMS WITH BEHCET'S DISEASE IN A JAPANESE POPULATION"],"prefix":"10.5387","volume":"58","author":[{"given":"NATSUMI","family":"SAKAMOTO","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"HIDEHARU","family":"SEKINE","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"HIROKO","family":"KOBAYASHI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"YUKIO","family":"SATO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"HIROMASA","family":"OHIRA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3342","reference":[{"key":"1","unstructured":"1. Wechsler B, Davatchi F, Mizushima Y, Hamza M, Dilsen N, Kansu E, Yazici H, Barnes CG, Chamberlain MA, James DG, Lehner T, O'Duffy JD, Rigby AS, Gregory J, Silman AJ. Criteria for diagnosis of Behcet's disease. Lancet, <b>335<\/b>: 1078-1080, 1990."},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Ohno S, Ohguchi M, Hirose S, Matsuda H, Wakisaka A, Aizawa M. Close association of HLA-Bw51 with Beh&ccedil;et's disease. Arch Ophthalmol, <b>100<\/b>: 1455-1458, 1982.","DOI":"10.1001\/archopht.1982.01030040433013"},{"key":"3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199910213411707"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Lehner T. The role of heat shock protein, microbial and autoimmune agents in the aetiology of Beh&ccedil;et's disease. Inter Rev Immunol, <b>14<\/b>: 21-32, 1997.","DOI":"10.3109\/08830189709116842"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Hemmi H, Takeuchi O, Kawai T, Kaisho T, Sato S, Sanjo H, Matsumoto M, Hoshino K, Wagner H, Takeda K, Akira S. A Toll-like receptor recognizes bacterial DNA. Nature, <b>408<\/b>: 740-745, 2000.","DOI":"10.1038\/35047123"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Alexopoulou L, Holt AC, Medzhitov R, Flavell RA. Recognition of double-stranded RNA and activation of NF-&kappa;B by Toll-like receptor 3. Nature, <b>413<\/b>: 732-738, 2001.","DOI":"10.1038\/35099560"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Leifer CA, Kennedy MN, Mazzoni A, Lee C, Kruhlak MJ, Segal DM. TLR9 is localized in the endoplasmic reticulum prior to stimulation. J Immunol, <b>173<\/b>: 1179-1183, 2004.","DOI":"10.4049\/jimmunol.173.2.1179"},{"key":"8","unstructured":"8. Takeshita F, Leifer CA, Gursel I, Ishii KJ, Takeshita S, Gursel M, Klinman DM. Cutting edge: Role of Toll-like receptor 9 in CpG-DNA-induced activation of human cells. J Immunol, <b>167<\/b>: 3555-3558, 2001."},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Ahmad-Nejad P, Hacker H, Rutz M, Bauer S, Vabulas RM, Wagner H. Bacterial CpG-DNA and lipopolysaccharides activate Toll-like receptors at distinct cellular compartments. Eur J Immunol, <b>32<\/b>: 1958-1968, 2002.","DOI":"10.1002\/1521-4141(200207)32:7<1958::AID-IMMU1958>3.0.CO;2-U"},{"key":"10","doi-asserted-by":"publisher","DOI":"10.1016\/0168-9525(87)90294-0"},{"key":"11","unstructured":"11. Lazarus R, Klimecki WT, Raby BA, Vercelli D, Palmer LJ, Kwiatkowski DJ, Silverman EK, Martinez F, Weiss ST. Single-nucleotide polymorphisms in the Toll-like receptor 9 gene (TLR9): frequencies, pairwise linkage disequilibrium, and haplotypes in three U.S. ethnic groups and exploratory case-control disease association studies. Genomics, <b>81<\/b>: 85-91, 2003."},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. T&ouml;r&ouml;k HP, Glas J, Tonenchi L, Bruennler G, Folwaczny M, Folwaczny C. Crohn's disease is associated with a toll-like receptor-9 polymorphism. J Gastroentero, <b>127<\/b>: 365-366, 2004.","DOI":"10.1053\/j.gastro.2004.05.051"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Sam-Agudu NA, Greene JA, Opoka RO, Kazura JW, Boivin MJ, Zimmerman PA, Riedesel MA, Bergemann TL, Schimmenti LA, John CC. TLR9 polymorphisms are associated with altered IFN-gamma levels in children with cerebral malaria. Am J Trop Med Hyg, <b>82<\/b>: 548-555, 2010.","DOI":"10.4269\/ajtmh.2010.09-0467"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Carvalho A, Pasqualotto AC, Pitzurra L, Romani L, Denning DW, Rodrigues F. Polymorphisms in toll-like receptor genes and susceptibility to pulmonary aspergillosis. J Infect Dis, <b>197<\/b>: 618-621, 2008.","DOI":"10.1086\/526500"},{"key":"15","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780310302"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. P&ouml;llinger B, Junt T, Metzler B, Walker UA, Tyndall A, Allard C, Bay S, Keller R, Raulf F, Di Padova F, O'Reilly T, Horwood NJ, Patel DD, Littlewood-Evans A. Th17 cells, not IL-17+ &gamma;&delta; T cells, drive arthritic bone destruction in mice and humans. J Immunol, <b>186<\/b>: 2602-2612, 2011.","DOI":"10.4049\/jimmunol.1003370"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Novak N, Yu CF, Bussmann C. Putative association of a TLR9 promoter polymorphism with atopic eczema. Allergy, <b>62<\/b>: 766-772, 2007.","DOI":"10.1111\/j.1398-9995.2007.01358.x"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Noguchi E, Nishimura F, Fukai H, Kim J, Ichikawa K, Shibasaki M, Arinami T. An association study of asthma and total serum immunoglobin E levels for Toll-like receptor polymorphisms in Japanese population. Clin Exp Allergy, <b>34<\/b>: 177-183, 2004.","DOI":"10.1111\/j.1365-2222.2004.01839.x"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Ito A, Ota M, Katsuyama Y, Inoko H, Ohno S, Mizuki N. Lack of association of Toll-like receptor 9 gene polymorphism with Beh&ccedil;et's disease in Japanese patients. Tissue Antigens, <b>70<\/b>: 423-426, 2007.","DOI":"10.1111\/j.1399-0039.2007.00924.x"},{"key":"20","unstructured":"20. Frassanito MA, Dammacco R, Cafforio P, Dammacco F. Th1 polarization of the immune response in Behcet's disease: a putative pathogenetic role of interleukin-12. Arthritis Rheum, <b>42<\/b>: 1967-1974, 1999."},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Kim GT, Cho ML, Park YE, Yoo WH, Kim JH, Oh HJ, Kim DS, Baek SH, Lee SH, Lee JH, Kim HY, Kim SI. Expression of TLR2, TLR4, and TLR9 in dermatomyositis and polymyositis. Clin Rheumatol, <b>29<\/b>: 273-279, 2010.","DOI":"10.1007\/s10067-009-1316-7"},{"key":"22","doi-asserted-by":"publisher","DOI":"10.1534\/genetics.103.024653"},{"key":"23","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/30.1.158"},{"key":"24","doi-asserted-by":"publisher","DOI":"10.1007\/s100380200092"}],"container-title":["FUKUSHIMA JOURNAL OF MEDICAL SCIENCE"],"original-title":[],"language":"en","deposited":{"date-parts":[[2021,5,20]],"date-time":"2021-05-20T19:15:13Z","timestamp":1621538113000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/fms\/58\/2\/58_127\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012]]},"references-count":24,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.5387\/fms.58.127","relation":{},"ISSN":["0016-2590","2185-4610"],"issn-type":[{"value":"0016-2590","type":"print"},{"value":"2185-4610","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012]]}}}